<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Frutiger-UltraBlack,Bold" color="#4d67ad"/>
	<fontspec id="font1" size="9" family="Frutiger-UltraBlack,Bold" color="#007682"/>
	<fontspec id="font2" size="9" family="Courier" color="#007682"/>
	<fontspec id="font3" size="9" family="Frutiger-Light" color="#000000"/>
	<fontspec id="font4" size="9" family="Arial" color="#000000"/>
	<fontspec id="font5" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font6" size="20" family="Frutiger-UltraBlack,Bold" color="#000000"/>
	<fontspec id="font7" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font8" size="14" family="GillSans-Light" color="#000000"/>
	<fontspec id="font9" size="16" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="15" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font11" size="11" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font12" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font13" size="6" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font14" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font15" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font16" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font17" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font18" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font19" size="8" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font20" size="8" family="GillSans,Bold" color="#000000"/>
<text top="44" left="508" width="67" height="9" font="font0" id="p1_t1" reading_order_no="2" segment_no="1" tag_type="title">Bio Med Central<a href="http://www.biomedcentral.com/"><b>Bio</b></a></text>
<text top="756" left="508" width="46" height="10" font="font4" id="p1_t2" reading_order_no="55" segment_no="24" tag_type="text">Page 1 of 8<a href="http://www.biomedcentral.com/"><b>Med</b></a></text>
<text top="769" left="432" width="122" height="8" font="font5" id="p1_t3" reading_order_no="56" segment_no="25" tag_type="text">(page number not for citation purposes)<a href="http://www.biomedcentral.com/">Central</a></text>
<text top="19" left="55" width="385" height="19" font="font6" id="p1_t4" reading_order_no="0" segment_no="0" tag_type="title">International Seminars in Surgical</text>
<text top="39" left="55" width="102" height="19" font="font6" id="p1_t5" reading_order_no="1" segment_no="0" tag_type="title">Oncology<i>(page number not for citation purposes)</i></text>
<text top="86" left="502" width="79" height="10" font="font7" id="p1_t6" reading_order_no="3" segment_no="2" tag_type="title">Open Access<b>International Seminars in Surgical </b></text>
<text top="87" left="55" width="50" height="13" font="font8" id="p1_t7" reading_order_no="4" segment_no="3" tag_type="title">Research<b>Oncology</b></text>
<text top="105" left="55" width="499" height="15" font="font9" id="p1_t8" reading_order_no="5" segment_no="4" tag_type="title">Research: Is resection of tumours involving the pelvic ring justified?<a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="123" left="55" width="252" height="15" font="font9" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="title">: A review of 49 consecutive cases</text>
<text top="140" left="55" width="358" height="14" font="font10" id="p1_t10" reading_order_no="7" segment_no="5" tag_type="text">Alex Yuen 1,3 , Eugene T Ek 1,3 and Peter FM Choong* 1,2,3<b>Research: Is resection of tumours involving the pelvic ring justified? </b></text>
<text top="175" left="55" width="488" height="9" font="font12" id="p1_t11" reading_order_no="8" segment_no="6" tag_type="text">Address: 1 Department of Orthopaedics, University of Melbourne, St. Vincent's Hospital, 41 Victoria Parade, Fitzroy, 3065, Victoria, Australia,<b>: A review of 49 consecutive cases</b></text>
<text top="185" left="55" width="499" height="8" font="font12" id="p1_t12" reading_order_no="9" segment_no="6" tag_type="text">2 Sarcoma Unit, Division of Surgical Oncology, Peter MacCallum Cancer Institute, Melbourne, Australia and 3 Department of Surgery, St. Vincent's</text>
<text top="195" left="55" width="213" height="8" font="font12" id="p1_t13" reading_order_no="10" segment_no="6" tag_type="text">Hospital, 41 Victoria Parade, Fitzroy, 3065, Victoria, Australia</text>
<text top="209" left="55" width="478" height="8" font="font12" id="p1_t14" reading_order_no="11" segment_no="7" tag_type="text">Email: Alex Yuen - ayuen7@hotmail.com; Eugene T Ek - Eugene.Ek@svhm.org.au; Peter FM Choong* - sarcomasurgeon@ozemail.com.au</text>
<text top="221" left="55" width="92" height="8" font="font12" id="p1_t15" reading_order_no="12" segment_no="8" tag_type="text">* Corresponding author</text>
<text top="369" left="112" width="44" height="10" font="font14" id="p1_t16" reading_order_no="22" segment_no="16" tag_type="title">Abstract</text>
<text top="384" left="112" width="385" height="9" font="font15" id="p1_t17" reading_order_no="23" segment_no="17" tag_type="text">Introduction: Pelvic surgery is challenging and impacts significantly on limb and visceral function,</text>
<text top="395" left="112" width="386" height="9" font="font16" id="p1_t18" reading_order_no="24" segment_no="17" tag_type="text">thus, raising the question "is heroic surgery justifiable". This study assessed the functional, oncologic</text>
<text top="407" left="112" width="228" height="9" font="font16" id="p1_t19" reading_order_no="25" segment_no="17" tag_type="text">and surgical outcomes following pelvis tumour resections.</text>
<text top="424" left="112" width="385" height="9" font="font15" id="p1_t20" reading_order_no="26" segment_no="18" tag_type="text">Methods: Between 1996–2003, 49 patients (mean age 43 years) underwent pelvic tumour</text>
<text top="436" left="112" width="386" height="9" font="font16" id="p1_t21" reading_order_no="27" segment_no="18" tag_type="text">resections- 38 primary malignant tumours, 5 secondary tumours and 6 benign tumours. Bone</text>
<text top="447" left="112" width="386" height="9" font="font16" id="p1_t22" reading_order_no="28" segment_no="18" tag_type="text">tumours comprised 5 osteosarcomas, 5 Ewings sarcomas, and 12 chondrosarcomas. Of the soft</text>
<text top="459" left="112" width="386" height="9" font="font16" id="p1_t23" reading_order_no="29" segment_no="18" tag_type="text">tumours, 9 were of neural origin. Tumours involved the ilium, acetabulum, pubic bones, sacrum or</text>
<text top="471" left="112" width="386" height="9" font="font16" id="p1_t24" reading_order_no="30" segment_no="18" tag_type="text">a combination of these. Functional assessment was performed and no patient had metastases at</text>
<text top="483" left="112" width="52" height="9" font="font16" id="p1_t25" reading_order_no="31" segment_no="18" tag_type="text">presentation.</text>
<text top="499" left="112" width="385" height="9" font="font15" id="p1_t26" reading_order_no="32" segment_no="19" tag_type="text">Results: There were 41 limb sparing resections and 8 hindquarter amputations. Surgical margins</text>
<text top="511" left="112" width="386" height="9" font="font16" id="p1_t27" reading_order_no="33" segment_no="19" tag_type="text">were intralesional (1), marginal (13), wide (26), and radical (3). Of limb sparing surgery, prosthetic<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15819994">  </a></text>
<text top="523" left="112" width="385" height="9" font="font16" id="p1_t28" reading_order_no="34" segment_no="19" tag_type="text">reconstructions were performed in 10 patients, biologic reconstructions in 6, a combination of<b>Abstract</b></text>
<text top="535" left="112" width="385" height="9" font="font16" id="p1_t29" reading_order_no="35" segment_no="19" tag_type="text">these in 3 and no reconstruction in others. There was 1 intraoperative death, 7 local recurrences<b>Introduction: </b></text>
<text top="546" left="112" width="386" height="9" font="font16" id="p1_t30" reading_order_no="36" segment_no="19" tag_type="text">and 19 metastases. Death from disease occurred at a mean of 14.2 months with a mean followup</text>
<text top="558" left="112" width="385" height="9" font="font16" id="p1_t31" reading_order_no="37" segment_no="19" tag_type="text">of 27 (1–96) months. Amputation and periacetabular resections had worse functional outcomes.</text>
<text top="570" left="112" width="172" height="9" font="font16" id="p1_t32" reading_order_no="38" segment_no="19" tag_type="text">Emotional acceptance was surprisingly high.</text>
<text top="587" left="112" width="385" height="9" font="font15" id="p1_t33" reading_order_no="39" segment_no="20" tag_type="text">Conclusion: Pelvic resections are complex. Functional outcome is significantly affected by surgery.<b>Methods: </b></text>
<text top="598" left="112" width="386" height="9" font="font16" id="p1_t34" reading_order_no="40" segment_no="20" tag_type="text">Disease control is similar to limb tumours. Emotional acceptance of surgery in survivors was</text>
<text top="610" left="112" width="284" height="9" font="font16" id="p1_t35" reading_order_no="41" segment_no="20" tag_type="text">surprisingly high. Major pelvic resection for malignancy appears justified.</text>
<text top="660" left="55" width="60" height="10" font="font14" id="p1_t36" reading_order_no="42" segment_no="22" tag_type="title">Background</text>
<text top="671" left="55" width="241" height="9" font="font17" id="p1_t37" reading_order_no="43" segment_no="23" tag_type="text">Pelvic resection is challenging and can have significant</text>
<text top="683" left="55" width="241" height="9" font="font17" id="p1_t38" reading_order_no="44" segment_no="23" tag_type="text">functional, social and psychological impact on the</text>
<text top="695" left="55" width="241" height="9" font="font17" id="p1_t39" reading_order_no="45" segment_no="23" tag_type="text">patient. It is also associated great morbidity especially</text>
<text top="706" left="55" width="241" height="9" font="font17" id="p1_t40" reading_order_no="46" segment_no="23" tag_type="text">when extensive resection is required to attain adequate<b>Results: </b></text>
<text top="718" left="55" width="241" height="9" font="font17" id="p1_t41" reading_order_no="47" segment_no="23" tag_type="text">surgical margins. With the introduction of adjuvant chem-</text>
<text top="730" left="55" width="241" height="9" font="font17" id="p1_t42" reading_order_no="48" segment_no="23" tag_type="text">otherapy and radiotherapy, and improved reconstruction</text>
<text top="659" left="313" width="241" height="9" font="font17" id="p1_t43" reading_order_no="49" segment_no="21" tag_type="text">techniques, limb- sparing surgery has largely replaced</text>
<text top="671" left="313" width="241" height="9" font="font17" id="p1_t44" reading_order_no="50" segment_no="21" tag_type="text">external hemipelvectomy. However, given the often poor</text>
<text top="683" left="313" width="241" height="9" font="font17" id="p1_t45" reading_order_no="51" segment_no="21" tag_type="text">prognosis of patients with pelvic tumours, the question of</text>
<text top="695" left="313" width="241" height="9" font="font17" id="p1_t46" reading_order_no="52" segment_no="21" tag_type="text">whether this type of surgery is justified remains unan-</text>
<text top="706" left="313" width="241" height="9" font="font17" id="p1_t47" reading_order_no="53" segment_no="21" tag_type="text">swered. This study assessed the functional, oncologic and</text>
<text top="718" left="313" width="223" height="9" font="font17" id="p1_t48" reading_order_no="54" segment_no="21" tag_type="text">surgical outcomes following pelvic tumour resection.<b>Conclusion: </b></text>
<text top="263" left="55" width="79" height="7" font="font18" id="p1_t49" reading_order_no="13" segment_no="9" tag_type="text">Published: 09 April 2005</text>
<text top="278" left="55" width="162" height="7" font="font19" id="p1_t50" reading_order_no="14" segment_no="12" tag_type="text">International Seminars in Surgical Oncology 2005, 2 :9</text>
<text top="278" left="226" width="88" height="7" font="font18" id="p1_t51" reading_order_no="15" segment_no="12" tag_type="text">doi:10.1186/1477-7800-2-9</text>
<text top="263" left="332" width="96" height="7" font="font18" id="p1_t52" reading_order_no="20" segment_no="10" tag_type="text">Received: 06 December 2004<b>Background</b></text>
<text top="273" left="332" width="79" height="7" font="font18" id="p1_t53" reading_order_no="21" segment_no="11" tag_type="text">Accepted: 09 April 2005</text>
<text top="292" left="55" width="227" height="7" font="font18" id="p1_t54" reading_order_no="16" segment_no="13" tag_type="text">This article is available from: http://www.issoonline.com/content/2/1/9</text>
<text top="306" left="55" width="159" height="7" font="font18" id="p1_t55" reading_order_no="17" segment_no="14" tag_type="text">© 2005 Yuen et al; licensee BioMed Central Ltd.</text>
<text top="315" left="55" width="492" height="7" font="font18" id="p1_t56" reading_order_no="18" segment_no="15" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),</text>
<text top="325" left="55" width="400" height="7" font="font18" id="p1_t57" reading_order_no="19" segment_no="15" tag_type="text">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</text>
</page>
</pdf2xml>
